897 filings
Page 11 of 45
8-K
q74bh95t1zoxfp4g
9 Dec 19
Windtree Therapeutics Completes $26.4 Million Private Placement
5:09pm
8-K
chr9ak4o577p14
28 Oct 19
Entry into a Material Definitive Agreement
4:40pm
8-K
r4sy2 9sp
25 Oct 19
Windtree Therapeutics Provides Business Update
5:17pm
8-K
ackyal
14 Aug 19
Windtree Therapeutics Reports Second Quarter 2019 Financial Results and Provides Key Business Updates
12:00am
DEF 14C
xkbr0exlx
18 Jul 19
Information statement
4:49pm
UPLOAD
mmj3q
18 Jul 19
Letter from SEC
12:00am
PRER14C
kuyfx
17 Jul 19
Preliminary revised information
5:29pm
CORRESP
nwkxnv3jtw2lz2zoakx3
17 Jul 19
Correspondence with SEC
12:00am
UPLOAD
gr73o5
3 Jul 19
Letter from SEC
12:00am
PRE 14C
zyvj72g0p4bs15pt5
24 Jun 19
Preliminary information
4:25pm
8-K
3n6hkl
31 May 19
Istaroxime Phase 2b Study Results Presented in Late Breaker Clinical Trial Session at the ESC Heart Failure Congress
4:17pm
NT 10-Q/A
o8mnys2znzn
16 May 19
Notice of late quarterly filing (amended)
9:46pm
EFFECT
usxxdk4
16 May 19
Notice of effectiveness
12:15am
NT 10-Q
vuqobxk
15 May 19
Notice of late quarterly filing
4:34pm
CORRESP
1m9wvr0nm1jbzd mk
15 May 19
Correspondence with SEC
12:00am
UPLOAD
n8fxmtqketx 9s
7 May 19
Letter from SEC
12:00am
8-K
rh2q4qtorw mhm
30 Apr 19
Windtree Therapeutics Appoints Daniel Geffken to Board of Directors
4:26pm